Impact of androgen deprivation therapy (ADT) on bone mineral density (BMD) over 3 years in men with nonmetastatic prostate cancer.

被引：0
|
作者：
Alibhai, Shabbir M. H.
Mohamedali, Hassanabbas Z.
Panju, Abbas H.
Timilshina, Narhari
Breunis, Henriette
Canning, Sarah Duff
Fleshner, Neil Eric
Krahn, Murray
Naglie, Gary
Tannock, Ian
Tomlinson, George A.
Warde, Padraig Richard
Cheung, Angela M.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, THETA, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M4X 1K9, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
193
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    R B Egerdie
    F Saad
    M R Smith
    T L J Tammela
    J Heracek
    P Sieber
    C Ke
    B Leder
    R Dansey
    C Goessl
    [J]. Prostate Cancer and Prostatic Diseases, 2012, 15 : 308 - 312
  • [42] A RESPONDER ANALYSIS OF THE EFFECTS OF DENOSUMAB ON BONE MINERAL DENSITY IN MEN WITH PROSTATE CANCER RECEIVING ANDROGEN DEPRIVATION THERAPY
    Egerdie, Blair
    Smith, Matthew R.
    Tammela, Teuvo L. J.
    Saad, Fred
    Ke, Chunlei
    Goessl, Carsten
    Dansey, Roger
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 611 - 611
  • [43] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    Egerdie, R. B.
    Saad, F.
    Smith, M. R.
    Tammela, T. L. J.
    Heracek, J.
    Sieber, P.
    Ke, C.
    Leder, B.
    Dansey, R.
    Goessl, C.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (03) : 308 - 312
  • [44] Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer
    Kiratli, BJ
    Srinivas, S
    Perkash, I
    Terris, MK
    [J]. UROLOGY, 2001, 57 (01) : 127 - 132
  • [45] Impact of androgen deprivation therapy on bone markers in men with localised prostate cancer
    Kuroda, I.
    Oyama, M.
    Yoshimura, I.
    Ueno, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 311 - 311
  • [46] Risk of subsequent dementia from androgen deprivation therapy (ADT) versus orchiectomy among men with prostate cancer.
    Parikh, Ravi Bharat
    Chhatre, Sumedha
    Malkowicz, S. Bruce
    Li, Bingnan
    Jayadevappa, Ravishankar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [47] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    S Yaturu
    S DjeDjos
    G Alferos
    C Deprisco
    [J]. Prostate Cancer and Prostatic Diseases, 2006, 9 : 35 - 38
  • [48] Impact of Androgen-Deprivation Therapy on Physical Function and Quality of Life in Men With Nonmetastatic Prostate Cancer
    Alibhai, Shabbir M. H.
    Breunis, Henriette
    Timilshina, Narhari
    Johnston, Calvin
    Tomlinson, George
    Tannock, Ian
    Krahn, Murray
    Fleshner, Neil E.
    Warde, Padraig
    Canning, Sarah Duff
    Klotz, Lawrence
    Naglie, Gary
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5038 - 5045
  • [49] Impact of Androgen Deprivation Therapy on Weight Gain Differs by Age in Men with Nonmetastatic Prostate Cancer REPLY
    Rais-Bahrami, Soroush
    Moreira, Daniel M.
    van Londen, G.
    Dew, M. A.
    [J]. JOURNAL OF UROLOGY, 2012, 188 (06): : 2189 - 2189
  • [50] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    Yaturu, S
    DjeDjos, S
    Alferos, G
    Deprisco, C
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 35 - 38
12345